Palladium-Catalyzed Asymmetric Phosphination. Scope, Mechanism, and Origin of Enantioselectivity by Blank, Natalia F, Moncarz, Jillian R, Brunker, Tim J, Scriban, Corina, Anderson, Brian J, Amir, Omar, Glueck, David S, Zakharov, Lev N, Golen, James A, Incarvito, Christopher D, Rheingold, Arnold L

Get full text

Enantioselective Synthesis of P-Stereogenic Benzophospholanes via Palladium-Catalyzed Intramolecular Cyclization by Brunker, Tim J, Anderson, Brian J, Blank, Natalia F, Glueck, David S, Rheingold, Arnold L

Get full text

Diastereoselective Synthesis of P‑Stereogenic Secondary Phosphine Oxides (SPOs) Bearing a Chiral Substituent by Ring Opening of (+)-Limonene Oxide with Primary Phosphido Nucleophil... by Zimmerman, Amber N, Xu, Rebecca S, Reynolds, Samantha C, Shipp, Chase A, Marshall, Derrick J, Wang, Ge, Blank, Natalia F, Gibbons, Sarah K, Hughes, Russell P, Glueck, David S, Balaich, Gary J, Rheingold, Arnold L

Get full text

Oxidative addition of methylene chloride to Me-DuPhos complexes of palladium and rhodium by Scheetz, Perry M., Blank, Natalia F., Gibbons, Sarah K., Glueck, David S., Rheingold, Arnold L.

Get full text

Synthesis and Structure of Platinum Bis(phospholane) Complexes Pt(diphos)(R)(X), Catalyst Precursors for Asymmetric Phosphine Alkylation by Guino-o, Marites A, Zureick, Andrew H, Blank, Natalia F, Anderson, Brian J, Chapp, Timothy W, Kim, Youngmin, Glueck, David S, Rheingold, Arnold L

Get full text

Chiral Palladium(0) trans-Stilbene Complexes:  Synthesis, Structure, and Oxidative Addition of Phenyl Iodide by Brunker, Tim J, Blank, Natalia F, Moncarz, Jillian R, Scriban, Corina, Anderson, Brian J, Glueck, David S, Zakharov, Lev N, Golen, James A, Sommer, Roger D, Incarvito, Christopher D, Rheingold, Arnold L

Get full text

Chirality Breeding via Asymmetric Phosphination. Palladium-Catalyzed Diastereoselective Synthesis of a P-Stereogenic Phosphine by Blank, Natalia F, McBroom, Katherine C, Glueck, David S, Kassel, W. Scott, Rheingold, Arnold L

Get full text

Synthesis, Structure, and Electrochemistry of an Electron-Rich Chiral Diaminoferrocene, (S,S)-Bis(2,5-dimethylpyrrolidinyl)ferrocene by Blank, Natalia F, Glueck, David S, Zakharov, Lev N, Rheingold, Arnold L, Saybolt, Matthew D, Ghent, Brenna L, Nataro, Chip

Get full text

Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial by Wedemeyer, Heiner, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Berger, Annemarie, Ciesek, Sandra, Manuilov, Dmitry, Mercier, Renee-Claude, Da, Ben L., Chee, Grace M., Li, Mingyang, Flaherty, John F., Lau, Audrey H., Osinusi, Anu, Schulze zur Wiesch, Julian, Cornberg, Markus, Zeuzem, Stefan, Lampertico, Pietro

Get full text

In-Depth Mechanistic Study on the Formation of Acrylamide and Other Vinylogous Compounds by the Maillard Reaction by Stadler, Richard H, Robert, Fabien, Riediker, Sonja, Varga, Natalia, Davidek, Tomas, Devaud, Stéphanie, Goldmann, Till, Hau, Jörg, Blank, Imre

Get full text

Efficacy and safety at 96 weeks of bulevirtide 2 mg or 10 mg monotherapy for chronic hepatitis D: results from an interim analysis of a phase 3 randomized study by Wedemeyer, Heiner, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Viacheslav, Morozov, Sagalova, Olga, Stepanova, Tatyana, Manuilov, Dmitry, Mercier, Renee-Claude, An, Qi, Flaherty, John F., Osinusi, Anu, Lau, Audrey, zur Wiesch, Julian Schulze, Cornberg, Markus, Zeuzem, Stefan, Lampertico, Pietro

Get full text

Acrylamide from Maillard reaction products by Stadler, Richard H, Blank, Imre, Varga, Natalia, Robert, Fabien, Hau, Jörg, Guy, Philippe A, Robert, Marie-Claude, Riediker, Sonja

Get full text

Efficacy and safety of bulevirtide monotherapy given at 2 mg or 10 mg dose level once daily for treatment of chronic hepatitis delta: week 48 primary end point results from a phase... by Wedemeyer, Heiner, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Viacheslav, Morozov, Sagalova, Olga, Stepanova, Tatyana, Manuilov, Dmitry, Suri, Vithika, An, Qi, Flaherty, John F., Osinusi, Anu, zur Wiesch, Julian Schulze, Cornberg, Markus, Zeuzem, Stefan, Lampertico, Pietro

Get full text

OS-068 - Efficacy and safety at 96 weeks of bulevirtide 2 mg or 10 mg monotherapy for chronic hepatitis D: results from an interim analysis of a phase 3 randomized study by Wedemeyer, Heiner, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Viacheslav, Morozov, Sagalova, Olga, Stepanova, Tatyana, Manuilov, Dmitry, Mercier, Renee-Claude, An, Qi, Flaherty, John F., Osinusi, Anu, Lau, Audrey, zur Wiesch, Julian Schulze, Cornberg, Markus, Zeuzem, Stefan, Lampertico, Pietro

Get full text

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer by Couch, Fergus J., Mendoza-Fandino, Gustavo A., Nord, Silje, Hallberg, Emily, Agata, Simona, Ahsan, Habibul, Aittomäki, Kristiina, Andrulis, Irene L., Anton-Culver, Hoda, Arndt, Volker, Arver, Brita, Barile, Monica, Benitez, Javier, Blank, Stephanie V., Blomqvist, Carl, Bonanni, Bernardo, Brauch, Hiltrud, Brenner, Hermann, Burwinkel, Barbara, Caligo, Maria A., Claes, Kathleen B. M., Cross, Simon S., Darabi, Hatef, de la Hoya, Miguel, Devilee, Peter, Dolcetti, Riccardo, Dorfling, Cecilia M., Försti, Asta, Foulkes, William D., Friebel, Tara, Gabrielson, Marike, Garber, Judy, Gaudet, Mia M., Gerdes, Anne-Marie, Ghoussaini, Maya, Goldgar, David E., Haeberle, Lothar, Hart, Steven, Healey, Sue, Herzog, Josef, Hogervorst, Frans B. L., Hopper, John L., Huzarski, Tomasz, Jakubowska, Anna, Janavicius, Ramunas, Jones, Michael, Kar, Siddhartha, Karlan, Beth Y., Knight, Julia A., Ko, Yon-Dschun, Konstantopoulou, Irene, Kwong, Ava, Liu, Jianjun, Manoukian, Siranoush, Margolin, Sara, Marme, Frederik, Miller, Austin, Montagna, Marco, Mulligan, Anna M., Nathanson, Katherine L., Olson, Janet E., Osorio, Ana, Park, Sue K., Peto, Julian, Pilarski, Robert, Poppe, Bruce, Rappaport, Christine, Rennert, Gad, Richardson, Andrea, Robson, Mark, Romieu, Isabelle, Rutgers, Emiel J., Sanchez, Maria-Jose, Sawyer, Elinor J., Schmidt, Marjanka K., Schmutzler, Rita K., Scott, Rodney, Senter, Leigha, Simard, Jacques, Sinilnikova, Olga M., Szabo, Csilla I., Tapper, William, Teixeira, Manuel R., Thomassen, Mads, Thompson, Deborah, Truong, Thérèse, Tsimiklis, Helen, Turnbull, Clare, Ursin, Giski, Weitzel, Jeffrey N., Whittemore, Alice, Wildiers, Hans, Yang, Xiaohong R., Zheng, Wei, Hall, Per, Kraft, Peter, Vachon, Celine, Slager, Susan, Monteiro, Alvaro A. N., Easton, Douglas F.

Get full text

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart by BARTNIK, Małgorzata, RYDEN, Lars, FERRARI, Roberto, MALMBERG, Klas, PYÖRÄLÄ, Kalevi, SIMOONS, Maarten, STANDL, Eberhard, SOLER-SOLER, Jordi, ÖHRVIK, John

Get full text

Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial by Wedemeyer, Heiner, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Berger, Annemarie, Ciesek, Sandra, Manuilov, Dmitry, Mercier, Renee-Claude, Da, Ben L, Chee, Grace M, Li, Mingyang, Flaherty, John F, Lau, Audrey H, Osinusi, Anu, Schulze Zur Wiesch, Julian, Cornberg, Markus, Zeuzem, Stefan, Lampertico, Pietro

Get full text